MKI67 and neoplasm: The World Health Organization (WHO) 2019 NET grading classification is focused on the biological traits of the tumor as they strongly influence prognosis [4]; as the Ki67 index and mitotic count increase, prognosis worsens (NET G3), even in the absence of nodal or liver metastatic disease [5].